Phase I/II Open Label Single Center Clinical Study Aimed to Evaluate the Safety and Efficacy of BonoFill-II in Reconstructing Bone in the Extremities
Phase of Trial: Phase I/II
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Human adipose-derived somatic cell therapy Bonus BioGroup (Primary)
- Indications Bone disorders
- Focus Adverse reactions
- Sponsors Bonus BioGroup
- 15 Jan 2019 Planned End Date changed from 1 Aug 2019 to 1 Dec 2019.
- 15 Jan 2019 Planned primary completion date changed from 1 Feb 2018 to 1 Sep 2019.
- 21 Jan 2018 Status changed from not yet recruiting to recruiting.